The Motley Fool

2 of the best ASX shares for Australia Day

The ASX will be closed on Monday 27 January for the Australia Day long weekend. This represents a great opportunity to review your share portfolio and watchlists, without all of the usual market noise. This is because it allows you to assess the performance of your stocks and their underlying businesses based on your own investment thesis.

Why have an investment thesis?

For each of your share market investments, it is good practice to write down your thoughts and the reasons why you purchased an investment, at the time you make a trade.

This makes it much easier to look back through the years and remember what made you confident enough to invest your hard earned money in that stock. If, when you look back at your initial investment thesis, you no longer agree with yourself or the investment thesis has changed, you can make an informed decision on owning a stock from that point in time forward.

2 ASX shares to consider over the Australia Day weekend

2 high quality ASX shares to consider writing an investment thesis for and adding to your portfolio over the long weekend are Macquarie Group Ltd (ASX: MQG) and CSL Limited (ASX: CSL).

The millionaire maker

Macquarie describes itself as “a diversified financial group providing clients with asset management and finance, banking, advisory and risk and capital solutions across debt, equity and commodities.” It lists the diversity of its operations, combined with a strong capital position and robust risk management framework as key contributors to its “50-year record of unbroken profitability.”

Macquarie has often been called the “millionaire maker”, and it is easy to see why. Macquarie shares are up by 133% over the last 5 years, before factoring in dividends. The stock currently sits on a price-to-earnings ratio of 15 and a partially franked dividend yield of 4.2%.

The global blood plasma giant

CSL has become a global biotech company by focusing on “saving lives and protecting the health of people who were stricken with a range of serious and chronic medical conditions”. The company has a number of products on the market, however its core product is its blood plasma collection business. Analysts believe that this business can grow by high single digits for the foreseeable future.

One of the keys to CSL’s share price success is the exceptional circa 40% return on equity that it generates. By historical measures, the cost of borrowing has been extremely low for a number of years now. This has enabled companies like CSL to use debt to fund some of their growth. 

For more great stocks for your watchlist, take a look at this insightful report.

Our Top 3 Blue Chip Shares To Buy Now

You’re invited! For a limited time, The Motley Fool Australia is giving away a fantastic FREE report detailing our 3 TOP BLUE CHIP SHARES to buy and own for now and beyond!.

So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!

Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...

While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...

Even better, Stock #3 offers a whopping grossed-up dividend of over 6%! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.

You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!


Motley Fool contributor Lloyd Prout has no position in any of the stocks mentioned and expresses his own opinions. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

FREE REPORT: Five Cheap and Good Stocks to Buy now…

Our Motley Fool experts have FREE report, detailing 5 dirt cheap shares that you can buy today.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.7% fully franked yield…

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.